Litcius/Paper detail

Impact of SGLT2-inhibitors on contrast-induced acute kidney injury in diabetic patients with acute myocardial infarction with and without chronic kidney disease: Insight from SGLT2-I AMI PROTECT registry

Pasquale Paolisso, Luca Bergamaschi, Arturo Cesaro, Emanuele Gallinoro, Felice Gragnano, Celestino Sardu, Niya Mileva, Alberto Foà, Matteo Armillotta, Angelo Sansonetti, Sara Amicone, Andrea Impellizzeri, Marta Belmonte, Giuseppe Esposito, Nuccia Morici, Jacopo Oreglia, Gianni Casella, Ciro Mauro, Dobrin Vassilev, Nazzareno Galiè, Gaetano Santulli, Paolo Calabrò, Emanuele Barbato, Raffaele Marfella, Carmine Pizzi

2023Diabetes Research and Clinical Practice80 citationsDOIOpen Access PDF

Topics & Concepts

MedicineKidney diseaseMyocardial infarctionInternal medicineDiabetes mellitusAcute kidney injuryRenal functionConventional PCICreatininePopulationRenal replacement therapyCardiologyEndocrinologyEnvironmental healthAcute Kidney Injury ResearchChronic Kidney Disease and DiabetesDiabetes Treatment and Management
Impact of SGLT2-inhibitors on contrast-induced acute kidney injury in diabetic patients with acute myocardial infarction with and without chronic kidney disease: Insight from SGLT2-I AMI PROTECT registry | Litcius